Replies to post #45526 on EP Global Communications Inc fka EPGL

[traderfromheaven]

utter non sense.. 1 good patent is enough to get 1.5 bils..

DNDN with 1 FDA approval went from 10 mil CAP to 5+ bils in few weeks...

next...

[Valiant]

Remember "TopSpin" is a game changing technology that allows EPGL to develop medical devices, procedures and process. If the patents and IP could potentially change the way every medical product or device is used then 1.5 Billion is a relatively conservative amount.

Most of the patents that you shared are old technology patents that was being bought up. Microsoft overpays for everything they buy, because they can. I wouldn't have paid $1 for AOL's patents.

[wobblenuts]

You know about the patents they are claiming and can for sure do some research on GAAP valuation standards, therefor, you or anyone else should be able to ballpark your own numbers and see for yourself.
Isn't that what the GAAP standards are for?

Your comparisons are invalid. Try and stay within the medical device industry.

W



FINANCIAL STATEMENT FOOTNOTE:
Asset valuation is based on best estimates of the value of the
following assets of EPGL, using multiple, GAAP valuation standards:

[Black8]

I beg to differ. The technology they have could be worth multiple billions, not just 1.5. Lol.

[lewsogge]

Apples to oranges. Medical technology is much more valuable than what you just compared EPGL's IP to. Successfully tapping one unmet medical market alone could easily generate $1.5 billion in a year. Keep in mind the expected sales for MPDD once it reaches full steam in the S-curve model for growth is $4.5 billion/year! Longs know the potential here and I for one am more than excited to wait. Some of their IP looks like it may have a much more explosive release into the market when that comes, too. While the S-curve is the norm for medical technology, something like a self powering contact lens could grab headlines nationwide (reminds me a lot of how MPDD was all over every major news agency when the first prototype was released and human trials showed huge success).